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Technology and the Creative 
Disruption of Health Care
by Maria João Maia, Institute for Technology 
Assessment and Systems Analysis, Karlsruhe
In many countries, health care is becoming in-
creasingly dependent on technology and medical 
devices due to a global demand for innovative 
medical technology solutions as a way to provide 
for an increasingly ageing population. This fact 
may also explain why it has been recognized that 
one of the major drivers of the increase in costs 
of health care is technology (Appleby 2013).
This year, in February, the Internation-
al Business to Business Forum for the Medical 
Devices Industry, took place in Stuttgart, Ger-
many. The Medical Devices Meetings is a busi-
ness platform dedicated to the entire value-added 
chain of the medical devices industry, aiming to 
strengthen, support and develop cooperation be-
tween stakeholders from the medical sector, such 
as industry developers and its representatives, 
research institutions and providers. This diversi-
ty of stakeholders was present in the event1, and 
some of them presented different types of med-
ical devices, several already identified with the 
capability to have a disruptive role in health care 
sector. For this reason, the aspect of disruption in 
health care deserves a closer look.
Acknowledging that not all disruptive tech-
nologies are indeed disruptive, Christensen pro-
posed the theory of disruptive innovation, argu-
ing that two conditions must be present: techno-
logical enablers and a disruptive business model 
(Christensen 1997). Basically, Christensen argues 
that a disruptive technology successfully targets a 
market segment that is usually overlooked, by de-
livering more -suitable functionality, frequently 
at a lower price (Christensen et al. 2015).
Many disruptive innovations result from the 
combination of one or more innovative technol-
ogies and their application through innovative 
business models (Barros et al. 2015). There-
fore, health organizations that embrace innova-
tive technologies and change the normality and 
standardization of organizational procedures 
and tasks, harness a new way of disruption, by 
changing how things are normally done. Aiming 
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for the enhancement of patient’s quality of life, 
disruptive innovations can introduce what is, un-
til the present moment, something uncommon in 
terms of medical practices, entangled with a new 
business model. For this reason, strategic plan-
ning of research and business and even a bit of 
audacity go hand-in-hand.
One can never say which path a disruptive 
innovation will take, meaning that they are un-
predictable in nature. This is reason why, a dis-
ruptive innovation can only be labelled has such, 
after its introduction or adoptation.
In health care, it is possible to identify main 
characteristics in disruptive innovations (Barros 
et al. 2015) such as:
- providing improved health outcomes,
- creating new services and overcoming chal-
lenges regarding accessibility to existing or 
new services,
- leading to cost-effective methodologies that 
improve access,
- promoting person-centred health delivery,
- empowering the patient/person,
- creating disorder in the old systems,
- creating new professional roles and capacities,
- creating new sets of values for the health work-
force, patients, citizens and community, and
- introducing transformative cultural change.
Disruptive innovations are innovations with the 
potential to promote organisational changes, 
including the creation of new networks by in-
volving new stakeholders, such as patients, over-
looked until recently, leading to the improvement 
of distribution of roles and values between them.
Some of the technologies, presented in the 
meeting, can be seen as a reshaping or upgrad-
ing of existing technologies in order to be more 
attractive or appealing to the users (clients), with 
a tendency to over- adding features that actual-
ly don’t necessarily have a real benefit for the 
end-user. They can be considered to be on the 
spectrum of “sustaining innovations”2. Sustain-
ing innovations, in general, tend to ignore what 
the normal, regular user is looking for in a health 
technology, which normally is a low-cost alter-
native, and also a technology that fits their needs. 
Other technologies presented at the meeting, 
already have the potential to be classified and 
others were already labelled as disruptive inno-
vations. Some, were even considered to be meg-
atrends in the context of future research policy 
by the OECD (OECD 2016), such as artificial in-
telligence, neurotechnologies, nanomaterials and 
addictive manufacturing3.
Inspired by the discussion and the presenta-
tions at the meeting, I will provide two examples 
of disruptive innovations. The first one, addic-
tive manufacturing which is becoming more and 
more dominant in medicine and health care and 
the other, minimally invasive surgery, with the 
example of surgical assisted robotics, already in 
a more advanced stage of research, development 
and implementation in hospitals.
1 Addictive Manufacturing (AM)
Products produced by addictive manufacturing 
can have different sources in terms of materials, 
such as metal, plastic, organic compounds or even 
human tissue, but, what they all have in common 
is the way they are produced: layer upon layer.
Despite its recent introduction in the field, 
research and applications of AM have been in-
creasing highly in the medicine and health care 
field. For instance, orthopaedics and prosthetics 
are a growing area of AM applications. Practi-
cal examples are implants and surgical fixation 
plates. The reason that they have such a high 
acceptance in surgery practice is due to the fact 
that they can be produced in a personalized way. 
Using a proper software, initial images acquired 
using, for instance, Computerized Tomography 
(CT) or Magnetic Resonance Imaging (MRI), the 
information obtained in the images can be up-
loaded and used for AM manufacturing technol-
ogy productions (Koptyug et al. 2013). Indeed, 
CT and MRI are considered to be the two most 
common imaging technologies for medically ap-
plied bioprinting (Shafiee/Atala 2016). The ma-
jor disadvantage already identified in this emerg-
ing field are related to required time and costs of 
the techniques (Martelli et al. 2016).
Despite these disadvantages, on the one 
hand AM produced implant models (such as ti-
tanium-aluminium-vanadium alloy) have proven 
to be less expensive, less wasteful in material, 
less energy demanding for manufacture. On the 
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other hand studies have showed that it is possi-
ble to optimize the manufacturing process, and 
therefore to reduce the costs for implants as well 
as delivery times (Koptyug et al. 2013).
3D printing techniques can also be used 
for preoperative planning (see e.g. Wake et al. 
2015), with the advantage of providing a better 
understanding of the complex anatomy and mor-
phology of the organs involved, providing for the 
possibility of surgeons training approach to the 
surgery planning.
Several challenges are still putting AM to 
the test, namely the issue of AM compounds and 
its sterilization. Since some materials are not 
resistant to extremely high temperatures, when 
submitted to sterilization procedures they suffer 
shape distortion from the model manufactured 
(Koptyug et al. 2013).
Another challenge is related to the biocom-
patibility of implant surface coating. It is not 
enough that the implant presents a good osseo-in-
tegration, fitting perfectly in terms of anatomy. It 
is mandatory that this new strange body is ac-
cepted by its user body. In order to be biocompat-
ible the coating of the implant has been improved 
over time, however due to being an emerging 
technology, there is not enough research yet on 
this topic and therefore studies on toxicology of 
the materials used for coating are needed.4
The reason of AM’s success in medicine is 
simple: freedom of component shape, personal-
ization and good value for money. Particularly in 
the case of impaired/disabled people, instead of 
mass-produced products, AM can provide a per-
sonalized product that targets exactly the need of 
the individual.5
Existing traditional medical implants are 
regulated and standardized in terms of shapes 
and sizes. AM implants are revolutionizing the 
existing standardization, towards a more effi-
cient personalized medicine. As a consequence, 
existing regulations should be reviewed in light 
of these new technologies.
Bio-printing has also been used for drug 
screening and delivery (Prasad/Smyth 2016), 
personalized medicine, fabrication and model-
ling of living organs for medical applications, 
and printing of cells, for tissue engineering and 
regenerative medicine (Shafiee/Atala 2016).
In terms of practical applications, the De-
partment of Cell and Tissue Engineering, of the 
Fraunhofer Institute (IGB), located in Stuttgart, 
Germany, is specialized in constructing human 
3D tissue. At the meeting, a patented skin mod-
el (three-dimensional two-layer human skin 
equivalent), a vascularized artificial skin and a 
prosthetic heart valve were presented. This new 
tissue has huge potential application in the field 
of regenerative medicine and for pharmaceutical 
testing. Another important collateral effect of the 
development of such tissue concerns the fact of 
the future absence of animal experiments and 
testing, in the field of medicine. A practical ap-
plication of tissue printing can be found in auric-
ular research, where printers are primarily used 
to create tissue-engineered constructs or manu-
facture artificial prostheses.
2 Minimal invasive surgery
Surgical robotic systems have different applica-
tions in medicine, such as tele-surgery, surgical 
rehearsal and pre-surgery planning, micro and 
nanobots and minimal invasive surgery (in the 
meeting, several examples were given by Cyrill 
von Tiesenhausen, Business Development Man-
ager Medical Robotic at KUKA Medical Robot-
ics, in his presentation “Lightweight robotics in 
Medicine”).
The introduction of assistive robotics tech-
nology for minimal invasive surgery, promoted 
several changes not only in the surgery proce-
dures and its associated consequences, but also 
changes concerning surgeon – patient interaction, 
work routines, professional competences, admin-
istration and management of medical departments 
(e.g. recovery room, operating room, etc.).
There are several clinical evidences that 
promote the use of surgical robots (as discussed 
in the meeting by Arnulf Stenzl, Director of the 
Department of Urology, from the University of 
Tübingen, in Germany, in his presentation “Ro-
bot-assisted surgery – The future begins today”) 
such as6 diminish of the size of the incision, di-
minish of blood losses and therefore diminish 
need of blood transfusion, less possibility of in-
fections, reduced post-surgery pain and due to 
these facts, shorter hospital stay due to reduce re-
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covery times (Lanfranco et al. 2004). These new 
clinical aspects lead to a reduction of the need 
for surgical hospital beds, which in some sys-
tems was a bottleneck for expansion of the vol-
ume of surgery, and also lead to the possibility of 
decentralisation of post-surgery care and options 
for day care surgery opening space to new or-
ganisational forms such as free standing surgical 
centres (Barros et al. 2015).
Concerning surgeon-patient interaction, 
having a technology as an extension of hers/his 
hands, the surgeon does not interact by touch with 
the patient’s tissue/organ anymore. The interac-
tion is made through the surgical robot, not giving 
the possibility (yet) for the surgeon to have haptic 
feedback (sensing) (Speich/Rosen 2004).
Several transformation of work in the oper-
ating room occur due to the introduction of robot-
ic assistive technology (Maia/Krings 2015). This 
new reality promotes strong changes in terms of 
medical competences, not only by the surgeon, 
but also for the rest of the surgical team. Since 
new and several technologies are introduced 
in the operating room, there is a need for new 
knowledge and new competences, concerning the 
surgical procedures and the handling of the tech-
nology. Less surgical time is proportional to stan-
dardization of procedures and right training of 
the surgeon as the surgical team. Others aspects 
to consider concern the separation of the surgical 
team, since the surgeon can be positioned in a dif-
ferent room, ergonomically seat and with her/his 
eyes in the stereoscopic cameras, communicating 
with the team via an inter-communicator.
The new approach to minimally invasive 
surgery, made surgery possible to patients that 
were inoperable due to their physical conditions, 
and patients whose pathology was still in the ear-
ly stages. This new fact leads to the inclusion of 
new patients in the “market”. As the technique 
started on this type of patients (lower end of 
the market) one could assist that slowly, it also 
disrupted the previous gold standard operations 
such as open chest or open abdomen surgery 
(Barros et al. 2015).
There are also some barriers to consider 
when it comes to assisted surgical robots, name-
ly existing legislation and also the lack of re-
imbursement by health insurance companies in 
these procedures.
Indeed, minimally invasive surgery disrupt-
ed not only the surgical procedures but also orga-
nizational aspects related to it, for this reasons, 
minimally invasive surgery is seen as a disrup-
tion of classical open.
3 Remarks
It is difficult to exactly predict which technol-
ogies and trends will transform and shape the 
course of healthcare, as disruptive innovation 
creates a new market and reshapes the existing 
ones. Disruptive innovations often provide a new 
and different perspective on things, a perspective 
that tends to reduce complexity in favour of the 
empowerment of the citizen/patient. For this 
reason, the lack of citizen’s/patient’s engage-
ment can be considered a possible barrier for 
disruptive technologies, since it is important to 
involve all the relevant actors in the creation and 
diffusion of (disruptive) innovations, in order to 
diminish the impact of vested interests that rep-
resent a barrier (Barros et al. 2015).
In order to ensure that all societal actors 
work together during the whole research and in-
novation process in order to better align both the 
process and outcomes, with the values, needs and 
expectations of the society in general (EC 2003), 
Responsible Research and Innovation (RRI) has 
a role to play by “including a better alignment 
of science (policies) with societal needs and the 
consideration of ethical aspects, the stimulation 
or implementation of inclusive and deliberative 
processes (stakeholder involvement and public 
engagement), and the sharing of responsibility 
for innovation processes among a wide range of 
stakeholders by means of early engagement and 
mutual learning” (Coenen 2016, p. 1). It is there-
fore important to involve health professionals in 
the process of creation and diffusion of (disrup-
tive) innovations, as well as involving citizens/
patients in the policy discussion on these issues.
Although fabricated 3D printing models are 
increasingly being used in surgery, aiding the 
surgeon to plan precisely and consider contour-
ing aspects of the surgery, the advantages and 
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disadvantages of their use remain to be investi-
gated (Martelli et al. 2016).
A major limitation of 3D printing is the time 
and cost needed to generate the 3D models. But 
as printers continue to expand their abilities, re-
duce cost, increase speed, and use a wider range 
of printable materials are expected. Printing bio-
compatible will change the existing approach to 
working with tissues at the cellular level, which 
will lead for potential advances in medicine.
In order to insure safety and conformity in 
the new products produced by AM, appropriated 
standards and regulations should be debated and 
developed.
Investigating the implications of disruptive 
innovation in training and education of clini-
cians, health care staff and other stakeholders 
should also be a major concern, since the tech-
nologies will be incorporated into their practice.
The implementation of any disruptive in-
novation, should carefully address the issues 
of relevance, equity (including access), quality, 
cost-effectiveness, person- and people centered-
ness, and sustainability (Barros et al. 2015).
Overall, after attending the Medical Device 
meeting, and having in mind that a disruptive 
innovation is a combination of a new business 
model associated with technology innovations, 
my impression is that the mechanism to identify 
technologies with the potential to become disrup-
tive should be more deeply researched, in order 
to reach a more creative disruption in health care.
The industry sector needs to focus on the 
true needs of patients and, in a broader analysis, 
on wider societal needs. More disruptive inno-
vations are needed in order to reach a more de-
sirable health care system. Three main questions 
should be addressed in advance: What will users 
really use the technology for? And in which ways 
the technology developed can help improve pa-
tient’s quality of life? When and how can patients 
be included in the process?
Technology Assessment and RRI need to 
play a more prominent role, not only by means 
of a participatory approach, by involving vari-
ous stakeholders, aiming to influence regulatory 
practices (by assessing the impacts of technolo-
gy) but also by combining this with a construc-
tive approach (associated with a responsible 
research and innovations approach), addressing 
social issues around technology and influencing 
design practices (by means of a more stakehold-
er involvement). Questions that need to be ad-
dressed are for example:
•	 What are the ethical and social implications 
associated with the use of such technologies 
(e.g. unintended harm)?
•	 Are the needs of citizens/patients clearly 
identified?
•	 Is there a gap in regulatory requirements con-
cerning safety and efficacy of such technolo-
gies?
•	 If so how can they be overcome?
•	 How can the different stakeholders work to-
gether during the process, and how can their 
different values, needs and expectations be 
aligned and feed back into development pro-
cesses?
•	 What is changing in health and care profes-
sional education? Which new professions can 
emerge and how can their competences be as-
sessed?
TA can play a role by identifying the innovations 
with the potential to be disruptive in health care 
and RRI can complement by attending to align 
research and innovation processes along the 
entire technology value chain, by engaging the 
different stakeholders in the process, and by also 
considering the real societal needs.
Further research on potential disruptive in-
novation and its impacts in healthcare is needed 
and must be foreseen, in order to better deal with 
the news challenges of tomorrow.
Notes
1) For more information concerning the event and 
its participants, please visit: http://www.medical-
devices-meetings.com
2) Sustaining innovations are considered to be inno-
vations that do not affect existing markets. They 
can be classified as continuous, if they improve a 
product in an existing market in ways that consu-
mers expect, or can be discontinuous if the inno-
vation is unexpected, but still not affecting exis-
tent markets (Barros et al. 2015).
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3) The internet of things, big data analysis and syn-
thetic biology are the other trends connected to the 
health care sector, identified in the OECD report.
4) Phillips and Smit Röntgen, present in the meeting 
their last research in additive metal manufacturing 
concerning tungsten 3D printing and powder de-
velopments used in medical devices. 
5) Besides health technologies, other examples of 
personalized technologies can be found as an 
answer to daily bases living, such has cutlery, 
glasses or cups, etc.
6) Although most of the literature refers to clini-
cal advantages, several studies also refer lack of 
enough clinical evidences (HIQA 2011).
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